IP Library Granted Patent US 9,907,726
Granted Patent B2
US 9,907,726 · App. 14/896,283 · Granted Mar 6, 2018

Injection bag and injection preparation assembly

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,907,726
App. No.
14/896,283
Granted
Mar 6, 2018
Kind
B2
Abstract

An injection bag is formed of a multilayer film, and includes an intermediate layer that includes a mixture of 60 to 90 mass % of a crystalline polyamide resin and 10 to 40 mass % of a noncrystalline polyamide resin. The crystalline polyamide resin has a combined content of a monomer and a low-molecular-weight polymer of 0.8 mass % or less. The noncrystalline polyamide resin includes a semi-aromatic polyamide.

Claims (28)

1. An injection bag that is formed of a multilayer film, the injection bag comprising:

an innermost layer that is formed of a polypropylene-based resin;

an outermost layer that is formed of a polypropylene-based resin;

an intermediate layer that is situated between the innermost layer and the outermost layer; and

two adhesive layers that are situated on either side of the intermediate layer,

the intermediate layer including a mixture of 60 to 90 mass % of a crystalline polyamide resin and 10 to 40 mass % of a noncrystalline polyamide resin,

the crystalline polyamide resin having a combined content of a monomer and a low-molecular-weight polymer of 0.8 mass % or less,

the noncrystalline polyamide resin including a semi-aromatic polyamide, and

the injection bag having a maximum UV absorbance measured in accordance with the Test Methods for Plastic Containers specified in the Japanese Pharmacopoeia 16th Edition of 0.08 or less.

2. The injection bag according to claim 1 , wherein the polypropylene-based resin of at least one of the outermost layer and the innermost layer contains a polyolefin-based resin other than the polypropylene-based resin.

3. The injection bag according to claim 1 or 2 , wherein the polypropylene-based resin has a flexural modulus of 300 to 700 MPa.

4. The injection bag according to claim 1 or 2 , wherein the polypropylene-based resin contains a polyolefin-based elastomer.

5. The injection bag according to claim 1 or 2 , wherein the intermediate layer has a thickness of 20 to 42 micrometers.

6. The injection bag according to claim 1 or 2 , wherein the crystalline polyamide resin is a polyamide 6-66 copolymer.

7. The injection bag according to claim 1 or 2 , wherein the noncrystalline polyamide resin is an isophthalic acid/terephthalic acid/hexamethylenediamine polycondensate.

8. The injection bag according to claim 1 or 2 , wherein part of the multilayer film on the inner side of the intermediate layer has a thickness of 70 micrometers or more.

9. An injection preparation assembly comprising the injection bag according to claim 1 or 2 , and a drug solution that is contained in the injection bag.

10. The injection preparation assembly according to claim 9 , wherein the injection bag is a multi-chamber container structure.

11. The injection preparation assembly according to claim 10 , wherein the drug solution contains bicarbonate ions.

12. The injection preparation assembly according to claim 11 , wherein the drug solution includes bicarbonate ions in an amount of 27 mEq/l or more.

13. The injection preparation assembly according to claim 9 , wherein the drug solution includes bicarbonate ions.

14. The injection preparation assembly according to claim 13 , wherein the drug solution includes bicarbonate ions in an amount of 27 mEq/l or more.

15. The injection preparation assembly according to claim 9 , wherein the polypropylene-based resin has a flexural modulus of 300 to 700 MPa.

16. The injection preparation assembly according to claim 9 , wherein the polypropylene-based resin contains a polyolefin-based elastomer.

17. The injection preparation assembly according to claim 9 , wherein the intermediate layer has a thickness of 20 to 42 micrometers.

18. The injection preparation assembly according to claim 9 , wherein the crystalline polyamide resin is a polyamide 6-66 copolymer.

19. The injection preparation assembly according to claim 9 , wherein the noncrystalline polyamide resin is an isophthalic acid/terephthalic acid/hexamethylenediamine polycondensate.

20. The injection preparation assembly according to claim 9 , wherein part of the multilayer film on the inner side of the intermediate layer has a thickness of 70 micrometers or more.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER INTERNATIONAL INC.
To: VANTIVE US HEALTHCARE LLC
Reel/Frame 074041/0853 →
SECURITY INTEREST Recorded Jan 31, 2025
From: VANTIVE US HEALTHCARE LLC; GAMBRO RENAL PRODUCTS, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 070076/0701 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2020
From: KEWPIE KABUSHIKI KAISHA (ALSO TRADING AS KEWPIE CORPORATION)
To: BAXTER INTERNATIONAL INC.
Reel/Frame 053695/0757 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2016
From: ISHINO, YOSHIKAZU; KAI, ZENICHIRO; SUEYOSHI, KOJI; WATANABE, KEN
To: KEWPIE KABUSHIKI KAISHA (ALSO TRADING AS KEWPIE CORPORATION); BAXTER INTERNATIONAL INCORPORATED
Reel/Frame 037969/0327 →